RCT

RCT stands for randomized controlled trial. It is the study design in which participants are assigned to intervention groups by chance rather than by researcher or participant choice, and outcomes are compared across groups whose assignment is known only after the analysis is complete. The randomization mechanism is what makes the comparison interpretable: it ensures that, on average, known and unknown prognostic factors are balanced across groups at baseline, so that observed outcome differences can be attributed to the intervention rather than to selection. The RCT is the reference design against which observational studies are evaluated for the purpose of causal inference.

The anatomy of a well-run RCT

A well-run RCT specifies its population, intervention, comparator, outcome measures, and analysis plan before enrollment begins. Allocation is concealed so that the investigator enrolling a participant does not know which arm the participant will land in. Blinding (single, double, or triple, depending on who is masked) prevents outcome ascertainment and analysis from being influenced by arm assignment. The primary analysis is typically intention-to-treat, meaning every randomized participant is analyzed in the arm to which they were assigned regardless of what actually happened after randomization; this preserves the protection from selection bias that randomization provides. CONSORT (Schulz et al., 2010, NLM 20332511) is the standard reporting framework and is required or strongly encouraged by most peer-reviewed journals.

Strengths and failure modes

RCTs are powerful because they break the link between the intervention and the many unmeasured factors that could otherwise confound an observational comparison. They are not infallible. They can fail when the trial is underpowered, when the chosen endpoint is not a good measure of the underlying construct, when dropout or crossover is large and nonrandom, when blinding is broken by a characteristic side effect, or when the population enrolled is not representative of the population to whom the finding is later applied. A careful read of a trial asks whether each of these failure modes is ruled out, not whether the headline result is statistically significant. A classic discussion of why RCTs sit at the top of the evidence hierarchy for interventional questions is Concato et al., NEJM 2000 (NLM 10861324).

RCT evidence in Open Assay content

When Open Assay pages reference RCT evidence, they do so as citations to specific published trials for the peptide under discussion, identified by trial registration ID (typically an NCT number at ClinicalTrials.gov) and by peer-reviewed publication. Open Assay does not use RCT citations to recommend any use of research materials; it uses them to locate a given peptide in the published scientific record.